熙菱信息(300588) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥48,137,751.08, representing a 68.78% increase compared to the same period last year[2] - The net profit attributable to shareholders was -¥4,406,499.57, an increase of 80.37% year-over-year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥10,142,471.66, reflecting a 57.84% increase compared to the previous year[2] - The basic and diluted earnings per share were both -¥0.0231, showing an 80.31% improvement year-over-year[2] - Net loss for Q3 2024 was CNY 25,528,443.53, an improvement from a net loss of CNY 33,442,099.70 in Q3 2023, reflecting a reduction in losses of about 23.7%[15] - Total comprehensive income for the third quarter was -24,051,094.41 CNY, an improvement from -31,500,002.95 CNY in the previous period[16] - Basic and diluted earnings per share were both -0.1338 CNY, compared to -0.1741 CNY in the previous period[16] Assets and Liabilities - The total assets at the end of the reporting period were ¥689,426,504.81, down 8.81% from the end of the previous year[2] - Total assets decreased to CNY 689,426,504.81 from CNY 756,004,197.77, a decline of approximately 8.8%[13] - Total liabilities decreased to CNY 331,997,860.53 from CNY 371,561,683.10, a reduction of about 10.6%[13] - Current liabilities totaled CNY 307,734,580.08, down from CNY 346,254,215.71, indicating a decrease of approximately 11.1%[13] - The company's equity attributable to shareholders decreased to CNY 357,428,644.28 from CNY 384,442,514.67, a decline of about 7.0%[13] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥48,817,827.27, a decrease of 165.69% year-over-year[2] - Cash inflow from operating activities totaled 154,679,433.81 CNY, down from 193,316,083.75 CNY in the previous period[17] - Cash outflow from operating activities was 203,497,261.08 CNY, resulting in a net cash flow from operating activities of -48,817,827.27 CNY, compared to -18,373,743.97 CNY previously[18] - Cash inflow from investment activities was 674,774,929.08 CNY, significantly lower than 1,335,137,735.21 CNY in the previous period[18] - Cash outflow from investment activities was 676,199,114.52 CNY, compared to 1,384,944,442.64 CNY in the previous period[18] - The net cash flow from investment activities was -1,424,185.44 CNY, an improvement from -49,806,707.43 CNY previously[18] - Cash inflow from financing activities was 625,000.00 CNY, down from 2,000,000.00 CNY in the previous period[18] - The net cash flow from financing activities was -10,234,680.66 CNY, compared to -15,035,183.74 CNY previously[18] - The ending cash and cash equivalents balance was 219,002,349.32 CNY, down from 232,271,454.11 CNY in the previous period[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 20,339[9] - The largest shareholder, He Kaiwen, holds 22.51% of the shares, totaling 43,104,000 shares[9] - The total number of shares held by the top ten shareholders accounts for a significant portion of the company's equity[9] - The company has a total of 46,998,375 restricted shares at the beginning of the period, with 10,792,500 shares added during the period[10] - The company plans to unlock 10,776,000 shares for He Kaiwen after the end of his term as a director[10] - The total number of restricted shares for Yue Yamei remains at 14,625,000, with no new additions during the period[10] Income and Expenses - The company received government subsidies amounting to ¥5,124,979.24 during the reporting period, contributing to other income[3] - The company reported a significant increase in other income, which rose by 125.49% year-over-year to ¥8,140,100[7] - Total operating revenue for Q3 2024 was CNY 114,108,732.70, an increase from CNY 111,112,946.76 in Q3 2023, representing a growth of approximately 2.7%[14] - Total operating costs decreased to CNY 161,077,435.97 from CNY 164,701,089.95, a reduction of about 2.0%[14] - Gross profit margin improved, with operating costs at CNY 71,181,173.09 compared to CNY 77,473,528.29, indicating a decrease in costs by approximately 8.4%[14] - Research and development expenses were CNY 12,945,333.43, slightly decreased from CNY 12,980,073.03, indicating a stable investment in innovation[15]